Search by Drug Name or NDC

    NDC 27241-0126-02 Ranolazine 1000 mg/1 Details

    Ranolazine 1000 mg/1

    Ranolazine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ajanta Pharma USA Inc.. The primary component is RANOLAZINE.

    Product Information

    NDC 27241-0126
    Product ID 27241-126_ca27bc3a-9222-41bb-9f61-e83485826eef
    Associated GPIs 32200040007430
    GCN Sequence Number 062973
    GCN Sequence Number Description ranolazine TAB ER 12H 1000 MG ORAL
    HIC3 A2C
    HIC3 Description ANTIANGINAL, ANTI-ISCHEMIC AGENTS,NON-HEMODYNAMIC
    GCN 98733
    HICL Sequence Number 033446
    HICL Sequence Number Description RANOLAZINE
    Brand/Generic Generic
    Proprietary Name Ranolazine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ranolazine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 1000
    Active Ingredient Units mg/1
    Substance Name RANOLAZINE
    Labeler Name Ajanta Pharma USA Inc.
    Pharmaceutical Class Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210054
    Listing Certified Through 2024-12-31

    Package

    NDC 27241-0126-02 (27241012602)

    NDC Package Code 27241-126-02
    Billing NDC 27241012602
    Package 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (27241-126-02)
    Marketing Start Date 2019-08-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.34116
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description RANOLAZINE ER 1,000 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 8bfd1a61-547a-4847-ae4e-480b17da6272 Details

    Revised: 11/2021